Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 InfectionHIV-1 InfectionActive, not recruitingPhase 22026-04-27NCT05729568

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Gilead Sciences180

34 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AIDS Arms, Inc. DBA Prism Health North TexasDallasUnited States2
Alfred HospitalMelbourneAustralia30
AXCES Research Group, LLCAlbuquerqueUnited States1
AXCES Research Group, LLCEl PasoUnited States6
Can Community Health CareFort LauderdaleUnited States1
Central Texas Clinical ResearchAustinUnited States13
Clinical Alliance for Research & Education, Infectious Diseases LLC (CARE-ID)AnnandaleUnited States1
Clinical Research Puerto RicoSan JuanPuerto Rico1
Duke University Health CenterDurhamUnited States2
East Sydney DoctorsDarlinghurstAustralia4
Emory University Hospital Midtown Infectious Disease ClinicAtlantaUnited States5
Georgetown University Medical CenterWashington D.C.United States62
Holdsworth House Medical PracticeSydneyAustralia1
Infectious Disease Specialists of AtlantaDecaturUnited States3
Maple Leaf Research/Maple Leaf Medical ClinicTorontoCanada1
Midland Florida Clinical Research Center, LLCDeLandUnited States6
Midway Immunology and Research CenterFt. PierceUnited States11
Mills Clinical ResearchLos AngelesUnited States8
Montefiore Medical CenterThe BronxUnited States198
NC TraCS Institute - CTRC; University of North Carolina at Chapel HillChapel HillUnited States2
Optimus Medical GroupSan FranciscoUnited States7
Orlando Immunology CenterOrlandoUnited States11
Prisma Health - Clinical Research UnitColumbiaUnited States1
Regional Center for Infectious Disease ResearchGreensboroUnited States1
Rosedale Health and WellnessHuntersvilleUnited States6